The health insurance company Cigna stopped coverage for $600 EpiPens and pharmacy chain CVS dramatically lowered prices for a competing device with a different brand name, dealing a blow to the EpiPen maker Mylan. (CNBC)
Cassandra Pollock was a state politics reporter for the Tribune. She joined the Tribune full-time in June 2017 after a fellowship during the 85th Texas Legislature. Pollock spent her first two years at... More by Cassandra Pollock

